<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://repozitorij.uni-lj.si/IzpisGradiva.php?id=162189"><dc:title>The role of quantitative imaging biomarkers in an early FDG-PET/CT for detection of immune-related adverse events in melanoma patients: a prospective study</dc:title><dc:creator>Hribernik,	Nežka	(Avtor)
	</dc:creator><dc:creator>Strašek Smrdel,	Katja	(Avtor)
	</dc:creator><dc:creator>Huff,	Daniel T.	(Avtor)
	</dc:creator><dc:creator>Studen,	Andrej	(Avtor)
	</dc:creator><dc:creator>Zevnik,	Katarina	(Avtor)
	</dc:creator><dc:creator>Škalič,	Katja	(Avtor)
	</dc:creator><dc:creator>Jeraj,	Robert	(Avtor)
	</dc:creator><dc:creator>Reberšek,	Martina	(Avtor)
	</dc:creator><dc:subject>medical imaging</dc:subject><dc:subject>FDG-PET/C</dc:subject><dc:subject>biomarkers</dc:subject><dc:subject>immunotherapy</dc:subject><dc:subject>immune checkpoint inhibitors</dc:subject><dc:description>Background. To  evaluate  the  role  of  the  novel  quantitative  imaging  biomarker  (QIB)  SUV$_{X\%}$  of  $^{18}$F-FDG  uptake  ex-tracted  from  early  18F-FDG  -PET/CT  scan  at  4  weeks  for  the  detection  of  immune-related  adverse  events  (rAE)  in  a  cohort of patients with metastatic melanoma (mM) patients receiving immune-checkpoint inhibitors (ICI). 

Patients and methods. In this prospective non-interventional, one-centre clinical study, patients with mM, receiv-ing ICI treatment, were regularly followed by $^{18}$F-FDG PET/CT. Patients were scanned at baseline, early point at week four (W4), week sixteen (W16) and week thirty-two (W32) after ICI initiation. A convolutional neural network (CNN) was used to segment three organs: lung, bowel, thyroid. QIB of irAE - SUV$_{X\%}$  - was analyzed within the target organs and correlated with the clinical irAE status. Area under the receiver-operating characteristic curve (AUROC) was used to quantify irAE detection performance.

Results. A  total  of  242  $^{18}$F-FDG  PET/CT  images  of  71  mM  patients  were  prospectively  collected  and  analysed.  The  early W4 scan showed improved detection only for the thyroid gland compared to W32 scan (p=0.047). The AUROC for detection of irAE in the three target organs was highest when SUV$_{X\%}$  was extracted from W16 scan and was 0.76 for lung, 0.53 for bowel and 0.81 for thyroid.  SUV$_{X\%}$  extracted from W4 scan did not improve detection of irAE compared to W16 scan (lung: p = 0.54, bowel: p = 0.75, thyroid: p = 0.3, DeLong test), as well as compared to W32 scan in lungs (p = 0.32) and bowel (p = 0.3).

Conclusions. Early  time  point  $^{18}$F-FDG  PET/CT  at  W4  did  not lead to statistically significant earlier detection ofirAE. However, organ18F-FDG uptake as quantified by SUV$_{X\%}$ proved to be a consistent QIB of irAE. To better assess the role of $^{18}$F-FDG PET/CT in irAE detection, the time evolution of $^{18}$F-FDG PET/CT quantifiable inflammation would be of essence, only achievable in multi centric studies.</dc:description><dc:date>2024</dc:date><dc:date>2024-09-19 13:40:14</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>162189</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
